North America Advanced Wound Care Market , Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

  • ID: 4583592
  • Report
  • Region: America, North America, United States
  • 100 pages
  • Data Bridge Market Research Private Limited
1 of 4

FEATURED COMPANIES

  • Acelity L.P. Inc
  • B.Braun Melsungen AG
  • Baxter,
  • Coloplast,
  • Convatec Inc
  • Derma Sciences Inc.
  • MORE
In this region, North America advanced wound care market is projected to hold the largest market share and growing at a significant CAGR in the forecast period 2018 to 2025.

The North America advanced wound care market is segmented on the basis of type, wound type, end user and distribution channels.

Based on type, the market is segmented into dressings, biologics and therapy devices

On the basis of Wound type, market is segmented into surgical wounds, diabetic ulcers, pressure ulcers, venous ulcers and burns

On the basis of end users, market is segmented into hospitals, wound care centers, ambulatory centres, home healthcare, clinics and community healthcare.

On the basis of distribution channels, market is segmented into direct drivers, retails. In 2018, direct tender is likely to rule the market and is also projected to grow with the highest CAGR in the forecast period 2018-2025.

Based on country, the North America advanced wound care market is segmented into 3 countries -
  • U.S.
  • Canada
  • Mexico
North America advanced wound care market competition by top players include -

Acelity L.P. Inc dominated the advanced wound care market accounting largest market share followed by Smith and Nephew, and Molnlycke Healthcare AB along with other players such as
  • Convatec Inc
  • Baxter,
  • Coloplast,
  • Ethicon. Inc
  • Integra Life Sciences Corporation
  • Derma Sciences Inc.
  • Organogenesis Inc,,
  • B.Braun Melsungen AG
  • Paul Hartmann Limited
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Acelity L.P. Inc
  • B.Braun Melsungen AG
  • Baxter,
  • Coloplast,
  • Convatec Inc
  • Derma Sciences Inc.
  • MORE
1 Introduction
1.1 Overview Of North America Advanced Wound Care Market
1.2 Currency And Pricing
1.3 Limitation
1.4 Markets Covered

2 Market Segmentation
2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.7 Secondary Sources
2.8 Assumptions

3 Market Overview
3.1 Drivers
3.1.1 Rising Ageing And Geriatric Population
3.1.2 Technological Advancement
3.1.3 Government Support
3.1.4 Rising Incidences Of Chronic Wound
3.1.5 Increasing Trend
3.2 Restraints
3.2.1 Low Awareness
3.2.2 Slow Growth Rate And Shrinking Market
3.2.3 Complex Regulatory Approval Process
3.2.4 Competition With Other Moist Dressings
3.3 Opportunities
3.3.1 Reimbursement
3.3.2 Mergers And Acquisitions To Expand Business
3.3.3 Unmet Needs
3.3.4 Increasing Demand
3.4 Challenges
3.4.1 Shortage Of Trained Staff
3.4.2 The Development Of Substitute Products
3.5 Key Market Trends And Upcomming Technologies
3.5.1 Smart Dressing Will Push Future Growth
3.5.2 Hydrofiber Has Been The Most Significant Recent Innovation
3.5.3 Alginate Dressing Is Expected To Grow Robustly In The Upcoming Years
3.5.4 Foam Dressing Accounting The Largest Market Segment In The Upcoming Years

4 Executive Summary

5 Premium Insights

6 North America Advanced Wound Care Market, By Product Type
6.1 Overview
6.2 Dressing
6.2.1 Dressing On The Basis Of Product Type
6.2.1.1 Film Dressings
6.2.1.2 Foam Dressings
6.2.1.3 Hydrogels
6.2.1.4 Alginates
6.2.1.5 Wound Contact Layer
6.2.1.6 Super Absorbent Dressing
6.3 Biologics
6.3.1 Biologics On The Basis Of Product Type
6.3.1.1 Allografts
6.3.1.2 Synthetic Skin Grafts
6.3.1.3 Xenografts
6.3.1.4 Growth Factors
6.3.1.4.1 Platelet Derived Growth Factor (Pdgf)
6.3.1.4.2 Platelet Rich Plasma (Prp)
6.3.1.4.3 Epidermal Growth Factors (Egf)
6.3.1.4.4 Basic Fibroblast Growth Factors (Bfgf)
6.3.1.4.5 Granulocyte Colony Stimulating Factor (G-Csf)
6.3.1.4.6 Talactoferrin Alfa
6.3.1.4.7 Thrombin Peptide
6.3.1.4.8 Keratinocy Growth Factor (Kgf)
6.4 Therapy Devices
6.4.1 Therapy Devices On The Basis Of Product Type
6.4.1.1 Negative Pressure Wound Therapy (Npwt)
6.4.1.1.1 Portable Npwt Devices
6.4.1.1.2 Disposable Npwt Devices
6.4.1.2 Pressure Relief Devices
6.4.1.3 Hyperbaric Oxygen Chambers
6.4.1.3.1 Monoplace
6.4.1.3.2 Multiplace
6.4.1.3.3 Topical
6.4.1.4 Wound Debridement Devices
6.4.1.4.1 Hydrosurgical
6.4.1.4.2 Ultrasound
6.4.1.4.3 Mechanical
6.4.1.4.4 Others
6.4.1.5 Physical Therapies
6.4.1.5.1 Laser Therapy
6.4.1.5.2 Electrical Stimulation
6.4.1.5.3 External Shock Wave Therapies
6.4.1.5.4 Saline Mist Therapy

7 North America Advanced Wound Care Market, By Wound Type
7.1 Introduction
7.2 Surgical Wound
7.2.1 Class I
7.2.2 Class Ii
7.2.3 Class Iii
7.2.4 Class Iv
7.3 Diabetic Ulcers
7.4 Pressure Ulcers
7.5 Venous Ulcers
7.6 Burns

8 North America Advanced Wound Care Market, By End User
8.1 Overview
8.2 Hospitals
8.3 Wound Care Centers
8.4 Ambulatory Centers
8.5 Home Healthcare
8.6 Clinics
8.7 Community Healthcare

9 North America Advanced Wound Care Market, By Distribution Channel
9.1 Overview
9.2 Direct Tenders
9.3 Retail

10 North America Advanced Wound Care Market By Geography
10.1 North America
10.1.1 U.S.
10.1.2 Canada
10.1.3 Mexico

11 North America Advanced Wound Care Market, Company Share
11.1 Company Share Analysis: North America

12 Company Profile
12.1 Acelity L.P. Inc. (Subsidary Of Allargan)
12.1.1 Company Overview
12.1.2 Company Share Analysis
12.1.3 Product Portfolio
12.1.4 Recent Developments
12.2 Smith And Nephew
12.2.1 Company Overview
12.2.2 Company Share Analysis
12.2.3 Revenue Analysis
12.2.4 Product Portfolio
12.2.5 Recent Developments
12.3 Molnlycke Healthcare
12.3.1 Company Overview
12.3.2 Company Share Analysis
12.3.3 North America Presence
12.3.4 Product Portfolio
12.3.5 Recent Developments
12.4 3M
12.4.1 Company Overview
12.4.2 Company Share Analysis
12.4.3 Revenue Analysis
12.4.4 Product Portfolio
12.4.5 Recent Developments
12.5 Baxter
12.5.1 Company Overview
12.5.2 Revenue Analysis
12.5.3 Product Portfolio
12.5.4 Recent Developments
12.6 Coloplast
12.6.1 Company Overview
12.6.2 Revenue Analysis
12.6.3 Product Portfolio
12.6.4 Recent Developments
12.7 Convatec Inc.
12.7.1 Company Overview
12.7.2 Revenue Analysis
12.7.3 Product Portfolio
12.7.4 Recent Developments
12.8 Derma Sciences Inc (Subsidiary Of Integra Life Sciences)
12.8.1 Company Overview
12.8.2 North America Presence
12.8.3 Product Portfolio
12.8.4 Recent Developments
12.9 Ethicon Inc (Subsidiary Of Johnson And Johnson Services, Inc )
12.9.1 Company Overview
12.9.2 North America Presence
12.9.3 Product Portfolio
12.9.4 Recent Developments
12.10 Integra Life Sciences Corporation
12.10.1 Company Overview
12.10.2 Revenue Analysis
12.10.3 Product Portfolio
12.10.4 Recent Developments
12.11 Paul Hartmann Limited
12.11.1 Company Overview
12.11.2 Revenue Analysis
12.11.3 Product Portfolio
12.11.4 Recent Development
12.12 Organogenesis Inc
12.12.1 Company Overview
12.12.2 North America Presence
12.12.3 Product Portfolio
12.12.4 Recent Developments

13 Related Reports
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Acelity L.P. Inc
  • Smith and Nephew
  • Molnlycke Healthcare AB
  • Convatec Inc
  • Baxter,
  • Coloplast,
  • Ethicon. Inc
  • Integra Life Sciences Corporation
  • Derma Sciences Inc.
  • Organogenesis Inc,,
  • B.Braun Melsungen AG
  • Paul Hartmann Limited
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll